MEDNAX, INC.: insider trades · United States · SEC (Form 4)

About MEDNAX, INC.

MEDNAX, Inc., now primarily operating under the Pediatrix Medical Group brand, is a US-listed healthcare services company traded on the NYSE under ticker MD in the United States. Founded in 1979 by Dr. Roger Medel, the business began as a single neonatology practice and evolved into a nationwide platform of physician-led specialty services. The company is headquartered in Florida and has built its model around affiliated medical practices, hospital-based clinicians, and integrated clinical support for health systems. MEDNAX’s core business is focused on women’s, babies’ and children’s health. Its principal service lines include neonatology, maternal-fetal medicine, obstetrics, pediatric hospitalist services, OB hospitalist services, pediatric intensive care, and a range of pediatric subspecialties. The company also offers related services such as newborn hearing screening and telehealth support for inpatient programs. In strategic terms, MEDNAX positions itself less as a simple staffing provider and more as a clinical partner to hospitals, helping them deliver specialized care across the continuum from delivery through neonatal and pediatric treatment. From a competitive standpoint, the group operates in highly specialized and operationally demanding niches where physician depth, quality performance, and hospital relationships are critical barriers to entry. Its national footprint is an important strength: recent company communications indicate support across 36 states through its network of affiliated practices. That broad reach gives it geographic diversification and access to a large number of hospital relationships, while its longstanding reputation in neonatology remains a central differentiator. The company’s specialization also makes it relevant to health systems seeking outsourced expertise in complex care settings. Recent developments have mainly centered on branding and strategic positioning. MEDNAX completed its transition to the Pediatrix brand across its affiliated practices, while keeping the MD ticker on the NYSE. In 2025, company communications highlighted Pediatrix as a trusted hospital solutions partner, emphasizing customized solutions designed to improve quality, contain costs, and mitigate risk. For investors, MEDNAX/Pediatrix is best viewed as a specialized US healthcare services platform with exposure to hospital volumes, reimbursement dynamics, labor availability, and demand for high-acuity maternal and pediatric care.